Metformin in gestational diabetes: the offspring follow up

Not Applicable

Recruiting

• Conditions: Gestational Diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12605000311651
• Lead Sponsor: HRC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Offspring of women who were randomsied in the metformin in geststional diabetes study

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Markers of adiposity in the offspring.[Measured at 2 years of age currently and will be remeasured through childhood.];Markers of insulin sensitivity in the offspring.[Measured at 2 years of age currently and will be remeasured through childhood.]

Secondary Outcome Measures

Name	Time	Method
eurodeveopmental [Assessment at age 2 years and at intervals through childhood.]